⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
globenewswire.com
TVTX
LGND
Form 8-K
sec.gov
SKYE
LGND
Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.
businesswire.com
LGND
Manufacturing Leaders Converged in Nashville for The Manufacturing & Automation eXchange (MAX)
accessnewswire.com
LGND
Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes
globenewswire.com
PFE
LLY
MGNX
LGND
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
globenewswire.com
LGND
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth USA - English USA - English
prnewswire.com
LGND
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
prnewswire.com
LGND
Ligand to Participate in March Investor Conferences
globenewswire.com
LGND
Form 8-K
sec.gov
LGNZZ
LGNYZ
LGNDZ
LGNXZ
LGND